KNE.V - Kane Biotech Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue283.278162.83536.174
Cost of Revenue92.63332.41716.895
Gross Profit190.645130.41819.279
Operating Expenses
Research Development427.593290.737653.916
Selling General and Administrative1,578.4381,000.415680.263
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-1,815.385-1,160.734-1,314.9
Income from Continuing Operations
Total Other Income/Expenses Net4.6916.3018.231
Earnings Before Interest and Taxes-1,810.694-1,154.434-1,306.668
Interest Expense89.86876.57787.597
Income Before Tax-1,900.562-1,231.011-1,394.265
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-1,900.562-1,231.011-1,394.265
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,900.562-1,231.011-1,394.265
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,900.562-1,231.011-1,394.265